Filopodia are thin, actin-based membrane protrusions with roles in sensing external mechanical and chemical cues, such as growth factor gradients in tissues. It was proposed that the chemical sensing role of filopodia is achieved through clearance of activated signaling receptors from filopodia. Type I insulin-like growth factor receptor (IGF1R) is a key regulator of normal development and growth, as well as tumor development and progression. Its biological roles depend on its activation upon IGF1 binding at the cell membrane. IGF1R behavior at the cell membrane and in particular in filopodia, has not been established. We found that IGF1 activation led to a gradual reduction in IGF1R puncta in filopodia, and that this clearance depended on actin, non-muscle myosin II, and IGF1R kinase activity. Using single particle tracking of filopodial IGF1R, we established that ligand-free IGF1R undergoes non-directional unidimensional diffusion along the filopodium. Moreover, after initial diffusion, the ligandbound IGF1R is actively transported along the filopodium towards the filopodium base, and consequently cleared from the filopodium. Our results show that IGF1R can move directionally on the plasma membrane protrusions, supporting a sensory role for filopodia in interpreting local IGF1 gradients.
Introduction
Filopodia are thin membrane protrusions of 100 to 200 nm diameter, containing 10-30 actin filaments bundled together by actin cross-linking proteins (Ridley, 2011; Zhuravlev et al., 2010) . The structure of filopodia is established dynamically: F-actin in filopodia undergoes retrograde flow, as G-actin monomers polymerize at the tip of filopodia and non-muscle myosin II moves F-actin bundles towards the cell body (Mattila and Lappalainen, 2008) . The filopodium can maintain a stable shape amidst this flux through integrin attachment at the tip (Zhang et al., 2004) , leading to establishment of a focal adhesion (Partridge and Marcantonio, 2006) . Filopodia have roles in sensing external mechanical and chemical cues, in cell migration and cell-cell interactions (Mattila and Lappalainen, 2008) , and are important for processes such as blood vessel formation (Lawson and Weinstein, 2002) , neuron pathfinding (Dent and Gertler, 2003) , wound healing (Noselli, 2002) , and cancer metastasis (Machesky, 2008) . The role of filopodia in sensing chemical cues has been proposed in various systems, including angiogenic sprouting in mouse retinal development (Gerhardt et al., 2003) , tracheal and wing disc morphogenesis in Drosophila (Ribeiro et al., 2002; Roy et al., 2011) and primordial germ cell polarization and migration in zebrafish (Meyen et al., 2015) . Clearance of activated signaling receptors from filopodia has been suggested as a potential mechanism for the proposed sensing role of filopodia (Lidke et al., 2005) .
The insulin-like growth factor receptor (IGF1R) plays diverse roles in development, growth, cell survival, and tumor invasion (Chitnis et al., 2008; LeRoith and Roberts, 2003) . IGF1R is a tyrosine kinase membrane receptor and a therapeutic target for antibodies and small molecule kinase inhibitors . IGF1R is activated upon binding of circulating IGF1 (or IGF2), which is predominantly released by the liver but also by other tissues, including muscle and cartilage (Laron, 2001) . Upon ligand-dependent autophosphorylation, IGF1R initiates downstream signaling, particularly through the phosphoinositide 3-kinase (PI3K) and mitogen-activated protein (MAP) kinase pathways (Chitnis et al., 2008) . Clearance of the activated receptor from the plasma membrane occurs through IGF1R internalization via clathrin-coated pits and caveolae (Matthews et al., 2008; Sehat et al., 2008) . IGF1 can act both as an endocrine hormone and as a paracrine hormone (Laron, 2001) , or even in an autocrine manner when secreted by cancer cells . IGF1 levels are not homogeneous around cells in the tissue-gradients of more than 10-fold difference in IGF concentration have been measured in human tissues (Desvigne et al., 2005) . Apart from the IGF1 secretion itself, gradients of IGF binding proteins (IGFBP) (Holly and Perks, 2006) , as found in the placenta (Han et al., 1996) , could also regulate the spatial complexity of IGF1R signaling. The importance of IGF1 in the development of the central nervous system, especially in neuronal migration and positioning (Hurtado-Chong et al., 2009) , and in post-wounding axonal sprouting (Guthrie et al., 1995) could be associated to IGF1 spatial gradients. These gradients could elicit cellular responses-IGF1 signaling has been shown to directly promote cell migration by stimulating membrane protrusions and directed cell migration (Guvakova et al., 2002; Haase et al., 2003) . The IGF1 receptor dynamics at the plasma membrane remain, however, poorly understood. In particular, its role and behavior in filopodia has never been addressed before. Here we investigated how IGF1R distribution in filopodia changed in response to receptor activation, how these changes were mediated, and then characterized the dynamics of ligand-free and ligand-bound IGF1R using single particle tracking.
Results and Discussion

IGF1 induces the clearance of IGF1R from filopodia in an actin-and non-muscle myosin
II-dependent manner
We studied the IGF1R distribution in filopodia in a human prostate carcinoma cell line (DU145) (Stone et al., 1978) -these cells express IGF1R and respond to IGF1 by increasing their invasive capacity (Saikali et al., 2008) . IGF1R staining in DU145 filopodia exhibited a punctate distribution (Fig. 1A) , and treatment with IGF1 for 30 minutes decreased the number of IGF1R puncta in filopodia ( Fig. 1A) . To further characterize this process, IGF1R signal in filopodia was measured at various times after IGF1 treatment ( Fig. 1B) . Filopodial IGF1R signal declined gradually, with ~37% depletion at 10 min and ~53% depletion at 30 min ( Fig.   1B ). To establish whether IGF1R tyrosine kinase activity is required for receptor clearance from filopodia, we treated cells with AZ12253801 (AZ), a small molecule inhibitor of IGF1R (Aleksic et al., 2010) . AZ fully inhibited the IGF1-induced filopodial clearance of IGF1R ( Fig.   1C ), suggesting IGF1 clearance in the filopodia requires IGF1R signaling. Receptor trafficking in specialized membrane protrusions such as filopodia can be achieved by tethering to actin cytoskeleton and myosin motors, as shown for integrins and myosin X (Zhang et al., 2004) .
We therefore hypothesized that IGF1R filopodial clearance could be driven by F-actin, which makes up the core of the filopodium. To explore the role of actin in the movement of IGF1R, we treated cells with cytochalasin D, which inhibits F-actin polymerization. Cytochalasin D blocked IGF-induced clearance (Fig. 1D, Fig. S1A ), indicating that actin polymerization is required for IGF1R transport in filopodia. The continuous transport of actin networks from the leading edge towards the cell body-actin retrograde flow-is maintained by non-muscle myosin II motor anchored near the 'minus' end, pulling the filaments inward (Medeiros et al., 2006; Mitchison and Kirschner, 1988; Ponti et al., 2004) . Myosin II was shown to localize to the base of filopodia and to be required for the retrograde transport of viruses on filopodia (Lehmann et al., 2005) , implying a role for myosin II-mediated contractility in retrograde actin flow in filopodia. To test the involvement of myosin II in IGF1R dynamics, we inhibited myosin II with blebbistatin, and this completely blocked IGF1R clearance ( Fig. 1E, Fig. S1B ).
Receptor clearance in filopodia seems thus to depend on both actin polymerization and myosin II contractility. As a control whether any cytoskeletal change was disruptive, we inhibited microtubule polymerization by using nocodazole. Nocodazole treatment had no effect on IGF1R clearance ( Fig. 1F, Fig. S1C ), consistent with the absence of microtubules from filopodia (Machesky, 2008; Mattila and Lappalainen, 2008) and indicating that IGF1R clearance was not sensitive to changes in microtubule stability in the cell. Filopodia are too narrow for endocytosis and do not contain clathrin (Mattila and Lappalainen, 2008) , but to determine whether the clearance of IGFR from filopodia depends on endocytosis from other domains of the plasma membrane, cells were treated with dynasore, a dynamin inhibitor that prevents clathrin-mediated and caveolar endocytosis (Macia et al., 2006) . IGF1 treatment still induced efficient clearance of IGF1R from filopodia in the presence of dynasore ( Fig. 1G ), suggesting that IGF1R clearance does not depend on endocytosis. Importantly, inhibitor treatments did not alter the levels of inactive IGF1R in filopodia, which were similar to the values obtained in control cells ( Fig. 1C-G) .
Ligand-free IGF1R undergoes diffusive motion on filopodia
IGF1R detection using immunofluorescence implies averaging behavior of many molecules, and real-time imaging of the IGF1R movement on filopodia has never been performed. To understand the dynamics of inactive, ligand-free IGF1R in filopodia, we employed live cell imaging and single particle tracking, using a specific affibody (a monomeric nonimmunoglobulin binding domain) against IGF1R (AffiIGF1R). This affibody binds IGF1R with high affinity and does not activate the receptor (Li et al., 2010) . AffiIGF1R was coupled with an acceptor peptide (AP) to enable site-specific biotinylation (bio-AffiIGF1R) (Fairhead et al., 2014) and subsequent labelling. We validated the specific binding of bio-AffiIGF1R to the receptor using HeLa cells transfected with IGF1R ( Fig. S2A) . To image ligand-free IGF1R, DU145 cells were labelled with bio-AffiIGF1R followed by streptavidin-labelled quantum dots (QDs) ( Fig. 2A) . The labelling was performed at low concentrations, in order to have one QD-bio-Affi complex per filopodium and facilitate single particle tracking. Three representative receptor trajectories from three independent experiments were overlaid on the corresponding QD-bio-AffiIGF1R images (projections) (Fig. 2B) . Displacement of the representative tracks shown in Figure 2B , plotted against time (Y-time plot), reveals that there is no systematic directional movement of the receptor during the observation period (Fig. 2C) . The nature of the ligand-free IGF1R motion was further analyzed by plotting mean squared displacement (MSD) versus time, which facilitates the classification of particle motion into free diffusion (straight-line for MSD v. time), active transport (MSD v. time curves up) and restricted diffusion (MSD v. time curves down) (Saxton and Jacobson, 1997) . MSD versus time plot of these trajectories gave an initial straight line, which later levelled off, consistent with confined diffusion (Fig. 2D) . The initial rate of diffusion, fit to a straight line to give a diffusion coefficient, showed heterogeneity in the diffusion rate of individual receptors (Fig. 2D) . The mean receptor diffusion rate (0.032 ± 0.006 µm 2 s -1 , N = 9) is close to the reported diffusion rates for EGFR dimer (Chung et al., 2010) . Analysis of directionality confirmed that the movement of IGF1R on filopodia is random, i.e. with a very low directionality index (0.018 ± 0.004, N = 9).
Ligand-bound IGF1R undergoes directed centripetal transport on filopodia
To understand the behavior of IGF1R on filopodia upon IGF1 binding, the motion of activated IGF1R was analyzed using biotinylated IGF1 (bio-IGF1). It was first determined whether bio-IGF1 bound specifically to IGF1R and not to other potential IGF1 receptors such as integrins (Fujita et al., 2012) , using the AffiIGF1R affibody ( Fig. S2B) . After pre-treating DU145 cells with a non-biotinylated AffiIGF1R (to block IGF1R), bio-IGF1 binding was abolished, suggesting that bio-IGF1 can be used to specifically label IGF1R (Fig. S2C) . For receptor tracking in real time, cell surface-bound bio-IGF1 was detected using streptavidin-QDs, both at low concentrations, to minimize potential receptor/QD clustering. Imaging and tracking of single QDs bound to IGF1 and activated IGF1R on filopodia revealed a directional centripetal movement of IGF1R towards the cell body, resulting in its clearance from the filopodium (Fig.   3A) . The directional movement was preceded by a period of random movement, as shown by three sample traces, with the trajectories overlaid on the corresponding image projections ( Fig. 3C ). The onset of centripetal directional movement was determined from time plots as a continuous directional movement, and was marked with arrows in Figure 4C . Interestingly, the fluctuating speeds of the representative IGF1-QDs undergo a transition to lower and more uniform speed values upon the onset of the centripetal movement, with occasional pausing (Fig. 3D) . IGF1-QD speed during the directional centripetal movement ranged 0-45 nm/s, with average speed of 12.2 ± 0.003 nm/s. MSD versus time curve analysis of the ligand-bound IGF1R motion (Fig. 3E) revealed a clear distinction between a period of random motion showing free diffusion, followed by a period of centripetal movement, which can be characterized as active transport. To confirm the nature of this active transport, we analyzed the directionality of motion, i.e. whether the ligand-bound receptor was as likely to move towards (centripetal motion) or away from the cell body. We found a 9-fold difference in directionality index between these two phases of activated IGF1R transport, showing a clear directionality of centripetal movement (Fig. 3F) . Taken together, our results underline that the directional centripetal movement of IGF1R on filopodia is dependent on receptor activation upon IGF1 binding; furthermore, we uncovered that this is an active transport, in contrast to the diffusive behavior of the ligand-free receptor.
Here we report that IGF1 receptor gets cleared from filopodia after activation mediated by IGF1 binding, through an active transport toward the cell body. In contrast, on the apical plasma membrane of DU145 cells (data not shown) and MCF-7 cells (Koner et al., 2013) , we have only observed Brownian diffusion of IGF1R, suggesting that this retrograde active transport is filopodium-specific. Our data point to myosin II-driven actin rearward flow as a probable mechanism for IGF1R trafficking on filopodia, in accordance with studies of viral particle transport and EGFR transport after ligand binding on filopodia (Lehmann et al., 2005; Lidke et al., 2004) . In agreement, the average speed of ligand-bound IGF1R during the centripetal transport on filopodia corresponds to rearward actin flow rate in filopodia, reported in mouse neuroblastoma cells (Mallavarapu and Mitchison, 1999) How IGF1R could leverage rearward actin flow to move centripetally on filopodia remains to be established. We hypothesize that receptor activation triggers recruitment of unidentified receptor-binding effectors, which would mediate receptor tethering to F-actin in filopodia and consequently promote receptor transfer, as the receptor was not shown to bind actin directly. Directed transport of IGF1R on filopodia could be used to enable fine-tuned sensing of local IGF1 gradients and thereby regulate cell behavior spatially, by directing cell migration and tissue organization. The observed activationdependent centripetal transport of IGF1R along the filopodia suggests a role in the adaptation of the sensing pathway by downregulating filopodial IGF1R in response to strong signals to help reset the system so that the cell is able to respond (again) to changes in ligand levels.
Materials and Methods
Reagents
Mouse (Mus musculus) monoclonal anti-IGF1R antibody (clone 24-31) recognizing the extracellular portion of IGF1R (Soos et al., 1992) was expressed and purified from the hybridoma, a kind gift of Ken Siddle (University of Cambridge). AffiIGF1R (Li et al., 2010) , the anti-IGF1R immunoglobulin-like binding protein bearing a C-terminal His6 tag and an Nterminal acceptor peptide (Beckett et al., 1999) , was generated from pET21b-ZSPA (Holm et al., 2009 ) by inverse PCR with the forward primer 5'-AATCGAAAACAGTCTACCGCATTTATTTCTAGCCTTGAAGATGACCCAAGCCAAA GCGCT and the reverse primer 5'-TAGATTCGGTAATGCCAGGATTTCGATTGCAGCATAGAAACCTTCTTTGTTGAAT TTGTTGTC. AffiIGF1R was expressed in E. coli and purified as previously described for ZSPA (Holm et al., 2009) . AffiIGF1R was biotinylated site-specifically with BirA, before dialysis into PBS (Holm et al., 2009) . Monovalent streptavidin (mSA) (Howarth et al., 2006 ) was expressed and purified as described (Howarth and Ting, 2008) , before conjugating to Alexa Fluor 555 succinimidyl ester (Life Technologies, Carlsbad, US) following manufacturer's instructions. to enhanced cyan fluorescent protein) has been described (Platani et al., 2002) . pEGFP-N1
containing Lifeact-monomeric enhanced green fluorescent protein (Lifeact-mGFP) (Riedl et al., 2008) was a kind gift of Dan Davis, Imperial College. Transient transfections were performed with Turbofect (Fermentas, St. Leon-Rot, Germany) according to the manufacturer's protocol.
IGF1R time-course assays
DU145 cells growing on glass coverslips were serum-starved overnight and then either pretreated with inhibitors or left untreated. The time-course was done by treating cells with 10 nM human des(1-3)IGF1 (ProSpec-Tany Technogene, Ness-Ziona, Israel) for 2, 5, 10 or 30 min at 37°C. Des(1-3)IGF1 binds like full-length IGF1 to IGF1R but avoids the complication of binding to IGFBPs (Ross et al., 1989) . Control cells were either incubated with the inhibitor, an equal concentration of dimethyl sulfoxide (DMSO) to that received by the inhibitor-treated cells, or left untreated for the same time period. After incubating with des(1-3)IGF1, cells were fixed with 3% (w/v) paraformaldehyde (Sigma-Aldrich, Gillingham, UK) for 20 min at 37ºC.
Immunofluorescence
Following fixation, paraformaldehyde was quenched with 50 mM ammonium chloride in PBS for 10 min at room temperature, and samples were blocked with 3% BSA in PBS for 30 min.
Surface IGF1R was labelled with 24-31 antibody at 4 µg/ml, followed by 10 µg/ml AlexaFluor 647-conjugated goat anti-mouse antibody (Life Technologies, Carlsbad, US), both for 1 h at room temperature. Cell membrane labeling was done for 10 min using 5 µg/ml WGA-AlexaFluor 488 (Life Technologies, Carlsbad, US) in PBS. Samples were mounted onto microscope slides using Prolong Gold Antifade reagent (Life Technologies, Carlsbad, US).
IGF1R labelling in living cells and time-lapse imaging
IGF1R labelling in living cells was done as described (Koner et al., 2013) , with some modifications. Briefly, DU145 cells growing in glass-bottom 35-mm imaging dishes (Willco, Amsterdam, Netherlands) were serum-starved overnight, rinsed with PBS-Mg and treated with 5 nM biotinylated human des(1-3) IGF1 (IBT, Binzwangen, Germany) or 5 nM biotin-AffiIGF1R in PBS-Mg containing 1% dialyzed BSA for 5 min. Des(1-3) IGF1 is a modified IGF1 with normal binding to IGF1R and minimized interaction with IGF binding proteins (IGFBPs) (Ross et al., 1989) . After three washes in PBS-Mg, 1 nM Qdot605-streptavidin (Life Technologies, Carlsbad, US) in PBS-Mg containing 1% dialyzed BSA was added to cells and incubated for 5 min. After three washes with PBS-Mg, L-15 Leibovitz medium (Life Technologies, Carlsbad, US) pre-warmed to 37°C was added and imaging started immediately.
Time-lapse movies (20 min duration; 1 s between frames) were taken using an incubated (37°C) wide-field DeltaVision Elite fluorescence microscope (Applied Precision, Washington, US) with 100× objective and optovar lens (1.6×), using softWoRx 5.0.0 software (Applied Precision, Washington, US). QDs were imaged with 490DF20 excitation, 617DF73 emission, and a Chroma 84100bs polychroic filter set using 0.2 s exposure. AlexaFluor 647 was imaged with 640DF20 excitation, 685DF40 emission, and a Chroma 84100bs polychroic filter set with 2 s exposure. AlexaFluor 488 was imaged with 490DF20 excitation, 528DF38 emission, and a Chroma 84100bs polychroic filter set with 0.1 s exposure. AlexaFluor 568 was imaged with 555DF28 excitation, 617DF73 emission, and a Chroma 84100bs polychroic filter set with 2 s exposure.
AffiIGF1R binding specificity
HeLa cells were transiently co-transfected with pcDNA3-IGF1R and Lifeact-mGFP plasmids Cells were washed with cold PBS-Mg and imaged as soon as possible. To further validate the specific binding of biotin-IGF1 to IGF1R, live DU145 cells were either pre-incubated with 55
µM non-biotinylated AffiIGF1R in PBS-Mg with 1% dialyzed BSA for 15 min at room temperature to block IGF1-binding on IGF1R, or left untreated. Then, cells were treated with 5 nM biotin-IGF1 in PBS-Mg with 1% dialyzed BSA for 5 min at room temperature, rinsed three times with PBS-Mg, and incubated with 1 nM Qdot605-streptavidin in PBS-Mg with 1% dialyzed BSA for 5 min at room temperature. The cells were placed on ice and imaged as soon as possible.
Image analysis and processing
All images were processed in ImageJ (v.1.46r; National Institutes of Health, USA). Analysis was done on fully spread, non-mitotic DU145 cells. Filopodia were identified based on their appearance in the WGA or differential interference contrast (DIC) channel, as unbranched, thin processes of uniform width (≤0.3 µm) along the axis, emanating from the cell periphery. The length of filopodia on DU145 cells varied from 1 to 12 µm while most of the values were in the 2-6 µm range; processes shorter than 1 µm were not analyzed. Time-lapse movie analysis was performed on stable filopodia of constant length throughout the movie. For time-course assays, RGB images were color-separated, converted to 8-bit grayscale images and background subtracted (ImageJ). Gaussian blur (radius 1; ImageJ) was applied in the representative images.
The regions of interest (ROI) (filopodia) were selected using a 5-pixel (0.33 µm) wide MSD analysis of AffiIGF1R-QD motion on filopodia. MSD values for the tracks shown in (B) were plotted. The first 5 points of the MSD plots were fit linearly to MSD=2D∆t (black lines)
to calculate initial diffusion rates, indicated on the graph.
